Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

163.30 USD -0.23 (-0.14%)
Streaming Delayed Price Updated: 10:10 AM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Nasdaq Biotechnology Ishares ETF

< Previous 1 2 3 4 Next >
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it has been added to the NASDAQ Biotechnology... 
From PR Newswire
Kamada Added to the NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Gamida Cell Added to NASDAQ Biotechnology Index
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that it has been selected for addition to the... 
From Business Wire News Releases
Poseida Therapeutics Added to NASDAQ Biotechnology Index
Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity... 
From PR Newswire
Spero Therapeutics Added to the NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Larimar Therapeutics Added to NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Applied Therapeutics to be Added to NASDAQ Biotechnology Index
From GlobeNewswire News Releases
MediciNova Added to the NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Immunic, Inc. Added to NASDAQ Biotechnology Index
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases,... 
From PR Newswire
Compugen Added to the NASDAQ Biotechnology Index
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has been selected for addition to the NASDAQ... 
From PR Newswire
Scholar Rock Added to NASDAQ Biotechnology Index
From GlobeNewswire News Releases
BioDelivery Sciences Added to NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Castle Biosciences Added to NASDAQ Biotechnology Index
Castle Biosciences was added to the NASDAQ Biotechnology Index (Nasdaq: NBI). 
From Business Wire News Releases
Affimed Announces Addition to NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Mirati Therapeutics Added To NASDAQ Biotechnology Index
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq: ^NBI). The... 
From PR Newswire
Strongbridge Biopharma plc Added to the NASDAQ Biotech Index
Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet... 
From GlobeNewswire News Releases
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index
Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) announced today that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:^NBI), which will become effective prior to... 
From Business Wire News Releases
BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF
BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB). 
From Business Wire News Releases
MediciNova Added to NASDAQ Biotechnology Index
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the Company... 
From GlobeNewswire News Releases
All Penny Stocks.com News: GeoVax Reports Positive Q3 Results, Shares Perk Higher
From SBWire - Latest Press Releases
All Penny Stocks.com News: Organovo Soars on Strong Customer Response for Its Second Tissue Service
From SBWire - Latest Press Releases
All Penny Stocks.com News: Cellceutix Phase 2 Trial Preliminary Data Shows Potential of Brilacidin
From SBWire - Latest Press Releases
All Penny Stocks.com News: Lipocine's Shares Surge as Company's Oral Testosterone Replacement Therapy Successful in Mid-Stage Study
From SBWire - Latest Press Releases
All Penny Stocks.com News: AXIM Biotechnologies Signs Distribution Agreement with Rafa Pharmaceuticals
From SBWire - Latest Press Releases
Biotech Industry on the Upswing after Rocky Start to 2016
From ACCESSWIRE
All Penny Stocks.com News: Soligenix Gets Additional Funding for OrbeShield
From SBWire - Latest Press Releases
AllPennyStocks.com News: Organovo Holdings Rallies as Company Signs First Customer Orders for Kidney Tissue Early Access Program
From SBWire - Latest Press Releases
Vista Partners Initiates Coverage on Mount TAM Biotechnologies, Inc. (Ticker: MNTM); $3.25 Price Target
From Marketwired News Releases
Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More 
From Marketwired News Releases
All Penny Stocks.com News: Aytu Bioscience Outlines Commercial Expansion Plans to Support Launch of New Drug
From SBWire - Latest Press Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X